These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15754629)

  • 1. [Role of interleukin-18, interleukin-1beta and its soluble receptor (sIL-1RII) in early and late Lyme borreliosis].
    Pietruczuk A; Swierzbińska R; Pietruczuk M; Hermanowska-Szpakowicz T
    Pol Merkur Lekarski; 2004 Nov; 17(101):446-50. PubMed ID: 15754629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concentration of interleukin-18, interleukin-1beta, soluble receptor for interleukin-1 (sIL-1RII) and C-reactive protein in patients with neuroborreliosis].
    Pietruczuk A; Swierzbińska R; Pietruczuk M; Kondrusik M; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T
    Neurol Neurochir Pol; 2005; 39(1):33-9. PubMed ID: 15735988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of interleukin-18 (IL-18), interleukin-1beta (IL-1beta), its soluble receptor sIL-1RII and C-reactive protein (CRP) in patients with Lyme arthritis.
    Pietruczuk A; Swierzbińska R; Pancewicz S; Pietruczuk M; Hermanowska-Szpakowicz T
    Infection; 2006 Jun; 34(3):158-62. PubMed ID: 16804660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of macrophage inflammatory proteins MIP-1alpha and MIP-1beta and interleukin 8 (il-8) in lyme borreliosis.
    Grygorczuk S; Pancewicz S; Zajkowska J; Kondrusik M; Rwierzbińska R; Hermanowska-Szpakowicz T
    Infection; 2004 Dec; 32(6):350-5. PubMed ID: 15597225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.
    Jouvenne P; Vannier E; Dinarello CA; Miossec P
    Arthritis Rheum; 1998 Jun; 41(6):1083-9. PubMed ID: 9627018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1 beta, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders.
    Tominaga K; Habu M; Sukedai M; Hirota Y; Takahashi T; Fukuda J
    Arch Oral Biol; 2004 Jun; 49(6):493-9. PubMed ID: 15099807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concentrations of pro-inflammatory cytokines IFN-gamma, IL-6, IL-12 and IL-15 in serum and cerebrospinal fluid in patients with neuroborreliosis undergoing antibiotic treatment].
    Pancewicz SA; Kondrusik M; Zajkowska J; Grygorczuk S
    Pol Merkur Lekarski; 2007 Apr; 22(130):275-9. PubMed ID: 17684925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
    Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
    J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease.
    Lindberg C; Chromek M; Ahrengart L; Brauner A; Schultzberg M; Garlind A
    Neurochem Int; 2005 Jun; 46(7):551-7. PubMed ID: 15843049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of IL-18 on IL-1beta and sIL-1RII production by human neutrophils.
    Jabłońska E; Izycka A; Wawrusiewicz N
    Arch Immunol Ther Exp (Warsz); 2002; 50(2):139-41. PubMed ID: 12022703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble IL-1RII and IL-18 are associated with incipient upper extremity soft tissue disorders.
    Rechardt M; Shiri R; Matikainen S; Viikari-Juntura E; Karppinen J; Alenius H
    Cytokine; 2011 May; 54(2):149-53. PubMed ID: 21371906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
    Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
    Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis.
    Grygorczuk S; Zajkowska J; Swierzbińska R; Pancewicz S; Kondrusik M; Hermanowska-Szpakowicz T
    Rocz Akad Med Bialymst; 2005; 50():173-8. PubMed ID: 16358960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis.
    Bellehumeur C; Collette T; Maheux R; Mailloux J; Villeneuve M; Akoum A
    Hum Reprod; 2005 May; 20(5):1177-84. PubMed ID: 15705625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of IL-15 on the secretion of IL-1beta, IL-1Ra and sIL-1RII by PMN from cancer patients.
    Jablonska E; Piotrowski L; Kiluk M; Jablonski J; Grabowska Z; Markiewicz W
    Cytokine; 2001 Dec; 16(5):173-7. PubMed ID: 11814312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome.
    Widhe M; Jarefors S; Ekerfelt C; Vrethem M; Bergstrom S; Forsberg P; Ernerudh J
    J Infect Dis; 2004 May; 189(10):1881-91. PubMed ID: 15122525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation.
    Docagne F; Campbell SJ; Bristow AF; Poole S; Vigues S; Guaza C; Perry VH; Anthony DC
    Eur J Neurosci; 2005 Mar; 21(5):1205-14. PubMed ID: 15813930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
    Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
    Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.